Form SC TO-T - Tender offer statement by Third Party:
SEC Accession No. 0001140361-23-041385
Filing Date
2023-08-28
Accepted
2023-08-28 08:23:56
Documents
18

Document Format Files

Seq Description Document Type Size
1 SC TO-T brhc20058012_sctot.htm SC TO-T 45075
2 EXHIBIT (A)(1)(A) brhc20058012_ex99-a1a.htm EX-99.(A)(1)(A) 517435
3 EXHIBIT (A)(1)(B) brhc20058012_ex99-a1b.htm EX-99.A1B 149486
4 EXHIBIT (A)(1)(C) brhc20058012_ex99-a1c.htm EX-99.(A)(1)(C) 13666
5 EXHIBIT (A)(1)(D) brhc20058012_ex99-a1d.htm EX-99.(A)(1)(D) 21896
6 EXHIBIT (A)(1)(F) brhc20058012_ex99-a1f.htm EX-99.(A)(1)(F) 36862
7 EXHIBIT (D)(2) brhc20058012_ex99-d2.htm EX-99.(D)(2) 146585
8 EXHIBIT (D)(4) brhc20058012_ex99-d4.htm EX-99.D 4 27094
9 EXHIBIT 107 brhc20058012_ex107.htm EX-FILING FEES 28982
10 image0.jpg GRAPHIC 29395
11 image00001.jpg GRAPHIC 51405
12 image00002.jpg GRAPHIC 162773
13 image00003.jpg GRAPHIC 204014
14 image00004.jpg GRAPHIC 161297
15 image00005.jpg GRAPHIC 176480
16 image00006.jpg GRAPHIC 156246
17 image00007.jpg GRAPHIC 56663
18 image00008.jpg GRAPHIC 1884
  Complete submission text file 0001140361-23-041385.txt   2367387
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Subject) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T | Act: 34 | File No.: 005-88971 | Film No.: 231210378
SIC: 2834 Pharmaceutical Preparations

Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filed by) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T
SIC: 2834 Pharmaceutical Preparations